Copertina

Comparing Equil patch versus traditional catheter insulin pump in type 2 diabetes using continuous glucose monitoring metrics and profiles

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yu‐Jiao Li, Zi‐Yue Shao, Yun‐Qing Zhu, Da‐Shuang Chen, Jian Zhu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Journal of Diabetes
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Faster‐acting insulin aspart versus insulin aspart for adults with type 1 diabetes treated with non‐automated insulin pump and continuous glucose monitoring—A double‐blind randomized controlled crossover trial
di: Ajenthen G. Ranjan, et al.
Pubblicazione: (2025)

An estimate of the need for continuous glucose monitoring in type 2 diabetes with intensive insulin treatment in secondary healthcare
di: Christian Trolle, et al.
Pubblicazione: (2024)

Automating insulin delivery through pump and continuous glucose monitoring connectivity: Maximizing opportunities to improve outcomes
di: Ananthi Anandhakrishnan, et al.
Pubblicazione: (2024)

Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
di: Howard Wolpert, et al.
Pubblicazione: (2025)

Cost‐effectiveness analysis comparing real‐time continuous glucose monitoring with self‐monitoring of blood glucose for patients with type 2 diabetes treated with insulin in Japan
di: Hirotaka Watada, et al.
Pubblicazione: (2026)

Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data
di: Xiaopeng Shao, et al.
Pubblicazione: (2024)

Impact of Omnipod 5 automated insulin delivery on continuous glucose monitoring metrics and predictors of improvement in time in range
di: Roland H. Stimson, et al.
Pubblicazione: (2025)

Real time continuous glucose monitoring in high‐risk people with insulin‐requiring type 2 diabetes: A randomised controlled trial
di: Claire S. Lever, et al.
Pubblicazione: (2024)

Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study
di: Michela Vergani, et al.
Pubblicazione: (2025)

Ketone test strip use is low in adults with type 1 diabetes and is not associated with HbA1c or glucose metrics on continuous glucose monitoring
di: Roland H. Stimson, et al.
Pubblicazione: (2026)

Differential effects of lifestyle interventions on continuous glucose monitoring metrics in persons with type 2 diabetes: Potential for personalised treatment
di: Iris M. de Hoogh, et al.
Pubblicazione: (2025)

Study of insulin infusion in diabetic rats with an ultra‐low‐cost insulin pump for managing blood glucose levels
di: Jhon E. Goez‐Mora, et al.
Pubblicazione: (2025)

Effect of iGlarLixi on continuous glucose monitoring—measured time in range in insulin‐naive adults with suboptimally controlled type 2 diabetes
di: Juan P. Frías, et al.
Pubblicazione: (2025)

Timing of insulin pump initiation among individuals with type 1 diabetes in Ontario, Canada
di: Xi Zhu, et al.
Pubblicazione: (2026)

Cost‐effectiveness analysis of Dexcom ONE + real‐time continuous glucose monitoring versus self‐monitoring of blood glucose in people with type 2 diabetes in Aotearoa New Zealand
di: Ryan G. Paul, et al.
Pubblicazione: (2026)

Unveiling glycaemic variability patterns linked to the triglyceride‐glucose index in type 2 diabetes: Insights from continuous glucose monitoring
di: Yunxiao Wu, et al.
Pubblicazione: (2026)

Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real‐world analysis
di: Satish K. Garg, et al.
Pubblicazione: (2024)

Withdrawal: Do we need continuous glucose monitoring in type 2 diabetes?
Pubblicazione: (2025)

Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐ 1 receptor agonist therapy in insulin‐treated diabetes
di: Irl B. Hirsch, et al.
Pubblicazione: (2024)

Satisfaction with continuous glucose monitoring and diabetes care among hospitalised patients with type 2 diabetes managed by inpatient diabetes teams
di: Mikkel Thor Olsen, et al.
Pubblicazione: (2025)

Effects of glucagon‐like peptide‐1 receptor agonists on glycated haemoglobin and continuous glucose monitoring metrics as adjunctive therapy to insulin in adults with type 1 diabetes: A meta‐analysis of randomized controlled trials
di: Paschalis Karakasis, et al.
Pubblicazione: (2024)

Extended use of real‐time continuous glucose monitoring in adults with insulin‐requiring type 2 diabetes: Results from the first 26 weeks of the 2GO‐CGM trial
di: Claire S. Lever, et al.
Pubblicazione: (2025)

Advances in continuous glucose monitoring and their impact on glycemic control in diabetes
di: Yi‐Hsuan Lai, et al.
Pubblicazione: (2026)

Heterogeneity of continuous glucose monitoring features and their clinical associations in a type 2 diabetes population
di: Elizabeth Healey, et al.
Pubblicazione: (2025)

Feasibility and benefits of continuous glucose monitoring for type 1 diabetes in Rwanda: A real‐world 12‐month continuation phase
di: Sandhya Narayanan, et al.
Pubblicazione: (2026)

Continuous glucose monitoring and all‐cause mortality in insulin‐using population with diabetes and cognitive impairment
di: Pareeta Kotecha, et al.
Pubblicazione: (2024)

Real‐world use of continuous glucose monitoring in people with type 2 diabetes and chronic kidney disease or on dialysis
di: Patrick McGown, et al.
Pubblicazione: (2025)

Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective
di: Stefano Del Prato, et al.
Pubblicazione: (2024)

Comparing the glycaemic outcomes between real‐time continuous glucose monitoring (rt‐CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials
di: Yongwen Zhou, et al.
Pubblicazione: (2024)

Effect of introduction of intermittently scanned continuous glucose monitoring on glycaemic control in individuals living with type 2 diabetes mellitus treated with non‐insulin therapies—A randomised controlled trial
di: Emmanuel Ssemmondo, et al.
Pubblicazione: (2024)

Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type
di: Roberto Franceschi, et al.
Pubblicazione: (2024)

Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial
di: Line Davidsen, et al.
Pubblicazione: (2025)

Clinical significance of coefficient of variation in continuous glucose monitoring for glycemic management in children and adolescents with type 1 diabetes
di: Tatsuhiko Urakami, et al.
Pubblicazione: (2024)

Safety and efficacy of hybrid closed‐loop insulin pump therapy in adolescents and adults with type 1 diabetes in China
di: Jing Shen, et al.
Pubblicazione: (2025)

Workplace‐based continuous glucose monitoring with structured education for pre‐diabetes and type 2 diabetes: A prospective community cohort study
di: Ji‐Hee Ko, et al.
Pubblicazione: (2025)

Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review
di: Nathaniel Foo, et al.
Pubblicazione: (2025)

No evidence from euglycaemic–hyperinsulinaemic clamp studies for greater insulin sensitivity in adults with type 1 diabetes using insulin pump versus multiple daily insulin injections—Post hoc meta‐analysis
di: Andrzej S. Januszewski, et al.
Pubblicazione: (2025)

Contributions of intermittently scanned continuous glucose monitoring frequency and bolus insulin dosing on time in range: Analysis of data from CGM and connected insulin pens
di: Pratik Choudhary, et al.
Pubblicazione: (2025)

Clinical outcomes of a real‐world prospective study using Dexcom ONE continuous glucose monitoring in people with diabetes treated with two or more insulin injections per day
di: Jackie Elliott, et al.
Pubblicazione: (2025)

Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice
di: Wanling Lu, et al.
Pubblicazione: (2025)